Two BioMed conferences co-organised by the IRB Barcelona and the BBVA Foundation have drawn more than 300 scientists from around the world to explore new developments in the fields of ageing and cancer. These conferences give researchers and experts an excellent platform through which to exchange ideas, foster collaborations, and improve our understanding of these challenging diseases.
- Dr. Raúl Méndez: Translational Control and Microenvironment in Cancer, The 37th Barcelona BioMed Conference
The meeting was organised by Dr. Raúl Méndez, an ICREA researcher, Dr. Alexandre David from the Institut de Génomique Fonctionelle (IGF, Montpelier, France), Dr. Fátima Gebauer from the Centre for Genomic Regulation (CRG, Barcelona) and Dr. Georg Stoecklin from the University of Heidelberg and the Zentrum für Molekulare Biologie der (ZMBH, Heidelberg, Germany). The conference focused on the study of the regulation of processes that may be the key to a potential therapeutic approach for cancer treatment and the study of the relationship between cancer cells and the tumoral microenvironment.
The meeting also featured numerous talks from promising young researchers, who brought new perspectives and dynamism to the programme. The Traslacore European Consortium on translation and cancer was created around this conference, bringing together around 80 expert research groups in this field.
For more information: https://www.irbbarcelona.org/en/news/institutional/translational-control-and-microenvironment-cancer-37th-barcelona-biomed
- Drs. Salvador Aznar-Benitah & Alejo Rodriguez-Fraticelli: The interplay between cancer and ageing under debate in Barcelona, The 38th Barcelona BioMed Conference
The conference aimed to identify common ground and advance knowledge, integrating the fields of ageing and cancer research. The conference featured 21 internationally recognised experts who presented their latest breakthroughs, including co-organisers Dr. Salvador Aznar-Benitah and Dr. Alejo Rodríguez-Fraticelli and Dr. John Dick, from the University Health Network of Toronto (Canada). The talks focused on the study of blood cells and diseases, epigenetics, clonal evolution, and the "omics" revolution, including technologies such as individual cell sequencing, quantitative genomics, and clonal analysis. To offer fresh viewpoints, the event featured poster sessions and talks by young researchers.
Dr. Aznar-Benitah stated that the conference had allowed them to invite the best scientists in the field and that it was an exceptional opportunity to exchange knowledge and ideas. Dr. Rodríguez-Fraticelli expressed that the conference had been a success as it had provided attendees with a new perspective, a broader vision of their field of study, and ideas for innovative research projects.
For more information: https://www.irbbarcelona.org/en/news/institutional/interplay-between-cancer-and-ageing-under-debate-barcelona
